Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pink Sheet Wants Your Feedback!

Say what you will about the climate in 2017 – regulatory, political, or otherwise – but we made it through the year. And the Pink Sheet is busy planning how to best help you make sense of and leverage the shifting tides in the biopharma industry in 2018.

To that end, we've kicked off an effort to reach out to you – our customers – to gain a better understanding of your challenges and needs so our plans reflect the right improvements to our content and its delivery. We hope you will be candid about your opinions as we fine-tune the Pink Sheet and the rest of Informa Pharma Intelligence's best-in-the-business publications.

Please tell us what you think by taking our brief "Pharma Feedback" survey. Everyone who completes the survey is eligible to enter a drawing to win one of four Amazon gift vouchers valued at $100 (US).

Thank you for reading us in 2017. We can't wait to continue the conversation this year!

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS122276

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel